Rybelsus 7 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FMSFU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,404
Award facts
- Contract value 100% obligated
- $11,403.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $11,403.52 delivery order on June 2, 2025, for the supply of Rybelsus 7 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion date of June 3, 2025, and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive portfolio of pharmaceutical deliveries to military and veteran healthcare systems, with this Rybelsus delivery supporting federal medical supply chain requirements.
This delivery order is issued under AmerisourceBergen's $999.999 billion Pharmaceutical Prime Vendor Global Program (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as the primary vehicle for supplying pharmaceutical products, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The Rybelsus product—a brand-name diabetes medication—aligns with AmerisourceBergen's established capability to deliver specialty medications across multiple therapeutic domains through competitively awarded contracts with predictable firm fixed pricing structures.
Quick answers
Who was awarded contract SPE2DB25FMSFU?
SPE2DB25FMSFU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FMSFU worth?
The government has obligated $11,404 on SPE2DB25FMSFU.
Is contract SPE2DB25FMSFU an order under another contract?
Yes. SPE2DB25FMSFU is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMSFU competed?
The extent of competition for SPE2DB25FMSFU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award